NCT03196219View on ClinicalTrials.gov

A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 7, 2017

Primary Completion Date

November 22, 2017

Study Completion Date

January 10, 2018

Conditions
Dental Caries
Interventions
DRUG

C16G2

C16G2

DRUG

Placebo

Varnish Placebo

Trial Locations (1)

59901

John F. Pittaway, DMD, Kalispell

Sponsors
All Listed Sponsors
lead

Armata Pharmaceuticals, Inc.

INDUSTRY